The Oncology Institute to Participate at Upcoming Investor Conferences
CERRITOS, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that senior management will participate at the following investor conferences:
Cowen 43rd Annual Healthcare Conference
Date: March 7th, 2023
Presentation: 2:50pm Eastern Time
TOI Participant: Daniel Virnich, M.D., MBA, President
Location: Boston, Massachusetts
Oppenheimer 33rd Annual Healthcare Conference
Date: March 13th, 2023
Presentation: 10:00am Eastern Time
TOI Participant: Brad Hively, Chief Executive Officer
Location: Virtual
Jefferies Value-Based Healthcare Summit
Date: March 13th, 2023
Presentation: 1:15pm Eastern Time
TOI Participant: Brad Hively, Chief Executive Officer
Location: Miami, Florida
Interested investors and other parties may listen to simultaneous webcasts of the presentations by logging onto the Investor Relations section of the Company’s website at /. The online replay will be available for a limited time shortly following the call.
About The Oncology Institute, Inc.
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
Contacts
Media
The Oncology Institute
Julie Korinke
(562) 735-3226 x 88806
Investors
Solebury Strategic Communications
Maria Lycouris
